IL-17 modulator 1 (disodium)
IL-17 modulator 1 (disodium) is an orally active, highly efficacious IL-17 modulator extracted from patent WO 2020127685. IL-17 modulator 1 (disodium) can be used for the research of diseases including psoriasis, ankylosing spondylitis and psoriatic arthritis[1].
Product Specifications
CAS Number
[2446803-91-2]
UNSPSC
12352005
Target
Interleukin Related
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Infection; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/il-17-modulator-1-disodium.html
Concentration
10mM
Purity
98.38
Solubility
DMSO : 20 mg/mL (ultrasonic; warming; heat to 80°C)
Smiles
O=C(C1=CC=NN1C(C)C)N[C@H](C(NC2=CC=C(C3=C(N(N=C3C)COP(O[Na])(O[Na])=O)C)C=C2)=O)C(C4CC4)C5CC5
Molecular Formula
C28H35N6Na2O6P
Molecular Weight
628.57
References & Citations
[1]WO 2020127685
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
IL-17
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
TNMD, ID (TNMD, CHM1L, Tenomodulin, Chondromodulin-1-like protein, Chondromodulin-I-like protein, Myodulin, Tendin) (Biotin) discontinued
EAPII, CT (TDP2, EAP2, TTRAP, Tyrosyl-DNA phosphodiesterase 2, 5'-tyrosyl-DNA phosphodiesterase, ETS1-associated protein 2, ETS1-associated protein II, TRAF and TNF receptor-associated protein) (APC)